Clinical trial
A Pivotal Clinical Trial of the Management of the Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System
NCT03319485 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal Clinical Trial of the Management of the Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 9, 2018
- Completion date
- August 31, 2026
- Enrollment
- 92 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.